We Stop at Nothing to End Cancer

Lifesaving Cancer Care Close to Home

This year, the COVID-19 pandemic has posed challenges for so many of our patients. People who are undergoing or have recently had chemotherapy are at high risk of complications from the coronavirus because of their compromised immune systems. We are participating in a National Cancer Institute clinical trial to determine whether COVID-19 affects therapies in cancer patients who acquire the virus. Meanwhile, we continue to provide full services and clinical trial options to our patients while taking exacting precautions for their safety and that of our staff.